Engineered FGF compositions and methods of use thereof.

by Kumar, Thallapuranam Krishnaswamy Suresh; Zaharoff, David A.; Jayanthi, Srinivas; Koppolu, Bhanuprasanth; Kerr, Rebecca; Balachandran, Kartik; McNabb, David S.

The present invention relates to the development of stable mutants of FGF-1 and FGF-2. In particular, it relates to novel engineered FGF-1 and FGF-2 polypeptides as well as polynucleotides, DNA constructs, and vectors encoding such polypeptides. In another aspect, pharmaceutical compositions and hydrogels including the disclosed polypeptides, polynucleotides, DNA constructs, and vectors are provided. In a still further aspect, methods of treating conditions using the compositions disclosed herein are provided.

Patent Number
USUS20170281790 A1 2017-10-05
Application Number
B2
Publication Year
2019
URL
https://scholarworks.uark.edu/pat/357